SE
Septerna Inc
SEPN · NASDAQ
$38.86 -1.67% (-$0.66)
1M -10.52%
Market Cap $1.75B
P/E Ratio -
Div. Yield -
ROE 6.31%
Piotroski F-Score Weak
3/9Valuation
55 /100
Fair P/S 17.71x
P/FCF 16.67x
P/B 4.53x
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
50 /100
Moderate Gross margin 99.57%
FCF margin 106.29%
Net margin 24.51%
Quality
2 /100
Poor ROIC 9.40%
Asset turnover 0.17x
ROE 6.31%
Debt
100 /100
Low Debt/Equity 0.06x
Current ratio 4.99x
Int. coverage N/A
Stability
1 /100
Unstable Beta 2.29x
Profitable years 0
EPS volatility 14,515.69%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SEPN
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jeffrey T. Finer
Employees
123
Headquarters
South San Francisco
Prihajajoči dogodki
09 NOV.
Earnings
Upcoming earnings report